Cho BC, Brana I, Cirauqui B, Aksoy S, et al. Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study. BMC Cancer 2024;23.
PMID: 39054467